Suppr超能文献

非编码 RNA 在三核苷酸重复神经退行性疾病中的作用。

Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.

机构信息

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.

出版信息

Exp Neurol. 2012 Jun;235(2):469-75. doi: 10.1016/j.expneurol.2012.01.019. Epub 2012 Jan 27.

Abstract

Increasingly complex networks of noncoding RNAs are being found to play important and diverse roles in the regulation of gene expression throughout the genome. Many lines of evidence are linking mutations and dysregulations of noncoding RNAs to a host of human diseases, and noncoding RNAs have been implicated in the molecular pathogenesis of some neurodegenerative disorders. The expansion of trinucleotide repeats is now recognized as a major cause of neurological disorders. Here we will review our current knowledge of the proposed mechanisms behind the involvement of noncoding RNAs in the molecular pathogenesis of neurodegenerative disorders, particularly the sequestration of specific RNA-binding proteins, the regulation of antisense transcripts, and the role of the microRNA pathway in the context of known neurodegenerative disorders caused by the expansion of trinucleotide repeats.

摘要

越来越多的非编码 RNA 复杂网络被发现,它们在整个基因组中对基因表达的调控起着重要而多样的作用。许多证据表明,非编码 RNA 的突变和失调与许多人类疾病有关,非编码 RNA 也与一些神经退行性疾病的分子发病机制有关。三核苷酸重复的扩展现在被认为是神经紊乱的主要原因。在这里,我们将回顾我们目前对非编码 RNA 参与神经退行性疾病分子发病机制的已知机制的认识,特别是特定 RNA 结合蛋白的隔离、反义转录本的调节,以及微 RNA 途径在由三核苷酸重复扩展引起的已知神经退行性疾病中的作用。

相似文献

1
Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders.
Exp Neurol. 2012 Jun;235(2):469-75. doi: 10.1016/j.expneurol.2012.01.019. Epub 2012 Jan 27.
2
Neurodegeneration as an RNA disorder.
Prog Neurobiol. 2012 Dec;99(3):293-315. doi: 10.1016/j.pneurobio.2012.09.006. Epub 2012 Oct 10.
3
[Research progress in roles of microRNA in polyglutamine diseases].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Aug;27(4):406-9. doi: 10.3760/cma.j.issn.1003-9406.2010.04.010.
4
Noncoding RNAs in protein clearance pathways: implications in neurodegenerative diseases.
J Genet. 2017 Mar;96(1):203-210. doi: 10.1007/s12041-017-0747-1.
5
Circular RNAs: the Emerging Class of Non-coding RNAs and Their Potential Role in Human Neurodegenerative Diseases.
Mol Neurobiol. 2017 Nov;54(9):7224-7234. doi: 10.1007/s12035-016-0213-8. Epub 2016 Oct 29.
6
[MicroRNAs and polyglutamine diseases].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Dec;30(6):683-6. doi: 10.3760/cma.j.issn.1003-9406.2013.06.011.
7
Non-coding RNAs with essential roles in neurodegenerative disorders.
Lancet Neurol. 2012 Feb;11(2):189-200. doi: 10.1016/S1474-4422(11)70286-1.
8
Non-Coding RNAs and Neurodegenerative Diseases: Information of their Roles in Apoptosis.
Mol Neurobiol. 2024 Jul;61(7):4508-4537. doi: 10.1007/s12035-023-03849-z. Epub 2023 Dec 16.
9
RNA metabolism in neurodegenerative disease.
Dis Model Mech. 2017 May 1;10(5):509-518. doi: 10.1242/dmm.028613.
10
Non-coding RNAs: New players in mitophagy and neurodegeneration.
Neurochem Int. 2022 Jan;152:105253. doi: 10.1016/j.neuint.2021.105253. Epub 2021 Dec 2.

引用本文的文献

1
The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.
Genes (Basel). 2025 Jan 2;16(1):48. doi: 10.3390/genes16010048.
2
Gene Alterations Induced by Glutamine (Q) Encoding CAG Repeats Associated with Neurodegeneration.
Methods Mol Biol. 2023;2575:3-23. doi: 10.1007/978-1-0716-2716-7_1.
3
A 1 bp deletion in HACE1 causes ataxia in Norwegian elkhound, black.
PLoS One. 2022 Jan 21;17(1):e0261845. doi: 10.1371/journal.pone.0261845. eCollection 2022.
5
Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1.
Mol Ther. 2020 Dec 2;28(12):2527-2539. doi: 10.1016/j.ymthe.2020.10.005. Epub 2020 Oct 14.
6
Motor Dysfunctions and Neuropathology in Mouse Models of Spinocerebellar Ataxia Type 2: A Comprehensive Review.
Front Neurosci. 2016 Dec 15;10:572. doi: 10.3389/fnins.2016.00572. eCollection 2016.
7
Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy.
Neurotherapeutics. 2013 Oct;10(4):621-31. doi: 10.1007/s13311-013-0212-7.
8
A brief history of triplet repeat diseases.
Methods Mol Biol. 2013;1010:3-17. doi: 10.1007/978-1-62703-411-1_1.
9
The unstable repeats--three evolving faces of neurological disease.
Neuron. 2013 Mar 6;77(5):825-43. doi: 10.1016/j.neuron.2013.02.022.
10
Approaches to manipulating microRNAs in neurogenesis.
Front Neurosci. 2013 Jan 17;6:196. doi: 10.3389/fnins.2012.00196. eCollection 2012.

本文引用的文献

3
Triplet repeat-derived siRNAs enhance RNA-mediated toxicity in a Drosophila model for myotonic dystrophy.
PLoS Genet. 2011 Mar;7(3):e1001340. doi: 10.1371/journal.pgen.1001340. Epub 2011 Mar 17.
4
Long tract of untranslated CAG repeats is deleterious in transgenic mice.
PLoS One. 2011 Jan 21;6(1):e16417. doi: 10.1371/journal.pone.0016417.
5
Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference.
Nucleic Acids Res. 2011 May;39(9):3852-63. doi: 10.1093/nar/gkq1323. Epub 2011 Jan 18.
6
Altered microRNA regulation in Huntington's disease models.
Exp Neurol. 2011 Jan;227(1):172-9. doi: 10.1016/j.expneurol.2010.10.012. Epub 2010 Oct 28.
7
Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans.
Cell Mol Life Sci. 2011 Apr;68(7):1255-67. doi: 10.1007/s00018-010-0522-4. Epub 2010 Sep 17.
8
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
Hum Mol Genet. 2010 Sep 15;19(18):3614-22. doi: 10.1093/hmg/ddq277. Epub 2010 Jul 5.
9
Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.
EMBO J. 2010 Apr 7;29(7):1248-61. doi: 10.1038/emboj.2010.21. Epub 2010 Feb 25.
10
Repeat expansion disease: progress and puzzles in disease pathogenesis.
Nat Rev Genet. 2010 Apr;11(4):247-58. doi: 10.1038/nrg2748.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验